4.5 Article

Periodontal Soft Tissue Non-Root Coverage Procedures: A Consensus Report From the AAP Regeneration Workshop

期刊

JOURNAL OF PERIODONTOLOGY
卷 86, 期 2, 页码 S73-S76

出版社

AMER ACAD PERIODONTOLOGY
DOI: 10.1902/jop.2015.140377

关键词

Gingival recession; periodontitis; regeneration; tissue engineering; tissue transplantation; surgery, plastic

资金

  1. Organogenesis (Canton, Massachusetts)
  2. Geistlich Pharma (Wolhusen, Switzerland)
  3. Institute Straumann (Basel, Switzerland)
  4. Keystone Dental (Burlington, Massachusetts)
  5. Biomet 3i (Palm Beach Gardens, Florida)
  6. Sunstar Americas (Chicago, Illinois)
  7. Nobel Biocare (Zurich, Switzerland)
  8. Zimmer Dental (Carlsbad, California)
  9. W. L. Gore & Associates (Flagstaff, Arizona)
  10. Geistlich Pharma
  11. Organogenesis
  12. Institute Straumann
  13. BioHorizons (Birmingham, Alabama)
  14. Osteohealth (Shirley, New York)
  15. Keystone Dental
  16. OraPharma (Horsham, Pennsylvania)
  17. Zimmer Dental
  18. AAP Foundation
  19. Geistlich Pharma North America
  20. Colgate-Palmolive
  21. Osteology Foundation

向作者/读者索取更多资源

Background: Soft tissue grafting for the purposes of increasing the width of keratinized tissue (KT) is an important aspect of periodontal treatment. A systematic review was analyzed, focusing on non-root coverage tissue grafts. The references were updated to reflect the current literature. Methods: To formulate the consensus report, group members submitted any new literature related to the topic that met criteria fitting the systematic review, and this information was reviewed for inclusion in this report. A consensus report was developed to summarize the findings from the systematic review and to guide clinicians in their treatment decision-making process. Results: Forty-six articles met the criteria for inclusion in the final analysis, and two articles were added that were used to formulate this consensus report. A list of eight clinically relevant questions was posed, and consensus statements were developed. Conclusions: The evidence suggests that a minimum amount of KT is not needed to prevent attachment loss (AL) when optimal plaque control is present. However, if plaque control is suboptimal, a minimum of 2 mm of KT is needed. The standard procedure to predictably gain KT is the autogenous gingival graft. There is limited evidence for alternative treatment options. However, additional research may offer promising results in certain clinical scenarios. Clinical Recommendations: Before patient treatment, the clinician should evaluate etiology, including the role of inflammation and various types of trauma that contribute to AL. The best outcome procedure (autograft) and alternative options should be reviewed with the patient during appropriate informed consent. Proper assessment of the outcome should be included during supportive periodontal care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据